Literature DB >> 8844498

Action of cyclosporin A on mononuclear phagocytes.

J E Losa García1, F Mateos Rodríguez, A Jiménez López, J L Pérez Arellano.   

Abstract

Classically, cyclosporin A has been reported to exert its immunomodulatory action through its effect on T lymphocytes by inhibiting the synthesis of interleukin 2. However, the inhibition of T-lymphocyte activation does not suitably account for all the effects observed following cyclosporin A administration. It is possible that some of them could be due to the action of cyclosporin A on other cells, among which are mononuclear phagocytes. This article offers a detailed review of the consequences of the interaction of cyclosporin A on the capacities (surface antigen expression and production of inflammatory mediators), functions (chemotaxis, phagocytosis, intracellular destruction and cytotoxicity) and actions (antimicrobial defense, antitumor defense and immune cooperation) of these cells. The general conclusion is that the capacities, functions and actions of the macrophages related to non-specific defense are more resistant to cyclosporin A than those related to immunoregulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844498

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  5 in total

1.  Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.

Authors:  Elizabeth A Mauldin; Daniel O Morris; Dorothy C Brown; Margret L Casal
Journal:  Vet Dermatol       Date:  2010-04-01       Impact factor: 1.589

2.  Calcineurin regulates innate antifungal immunity in neutrophils.

Authors:  Matthew B Greenblatt; Antonios Aliprantis; Bella Hu; Laurie H Glimcher
Journal:  J Exp Med       Date:  2010-04-26       Impact factor: 14.307

3.  Effect of cyclosporin A on inflammatory cytokine production by U937 monocyte-like cells.

Authors:  J E Garcia; M R de Cabo; F M Rodríguez; J P Losada; A J López; J L Arellano
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

4.  Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level.

Authors:  J E García; A M López; M R de Cabo; F M Rodríguez; J P Losada; R G Sarmiento; A J López; J L Arellano
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

5.  A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus.

Authors:  Raghu Ganugula; Meenakshi Arora; Dianxiong Zou; Sandeep K Agarwal; Chandra Mohan; M N V Ravi Kumar
Journal:  Sci Adv       Date:  2020-06-12       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.